TMDX

TransMedics Group, Inc. Common Stock

72.06

USD

-0.34

-0.47%

Oct 22, 15:58 UTC -4

Closed

After-Market

72.13

+0.06

+0.09%

TransMedics Group, Inc. Common Stock (TMDX) Earnings

TMDX Earnings Reports

Positive Surprise Ratio

TMDX beat 18 of 30 last estimates.

60%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$181.14M

$0.29

Implied change from Q2 26 (Revenue/ EPS)

-4.64%

-34.09%

Implied change from Q3 25 (Revenue/ EPS)

+25.94%

-56.06%

TransMedics Group, Inc. Common Stock earnings per share and revenue

On Aug 04, 2026, TMDX reported earnings of 0.44 USD per share (EPS) for Q2 26, missing the estimate of 0.48 USD, resulting in a -8.86% surprise. Revenue reached 189.95 million, compared to an expected 187.31 million, with a 1.41% difference. The market reacted with a -5.28% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 12 analysts forecast an EPS of 0.29 USD, with revenue projected to reach 181.14 million USD, implying an decrease of -34.09% EPS, and decrease of -4.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Thermo Fisher Scientific, Inc.

Report Date

Oct 21, 2026 For Q3 26

Estimate

$6.46

Actual

$6.68

Surprise

+3.29%

Intuitive Surgical Inc.

Report Date

Oct 20, 2026 For Q3 26

Estimate

$2.69

Actual

$3.00

Surprise

+11.30%

Integra LifeSciences Holdings

Report Date

Oct 21, 2026 For Q3 26

Estimate

$0.57

Actual

$0.59

Surprise

+3.04%

AngioDynamics, Inc.

Report Date

Oct 08, 2026 For Q1 27

Estimate

-$0.11

Actual

-$0.04

Surprise

+65.40%

FAQ

What were TransMedics Group, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, TransMedics Group, Inc. Common Stock reported EPS of $0.44, missing estimates by -8.86%, and revenue of $189.95M, 1.41% above expectations.

How did the market react to TransMedics Group, Inc. Common Stock's Q2 2026 earnings?

The stock price moved down -5.28%, changed from $80.75 before the earnings release to $76.49 the day after.

When is TransMedics Group, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for TransMedics Group, Inc. Common Stock's next earnings report?

Based on 12 analysts, TransMedics Group, Inc. Common Stock is expected to report EPS of $0.29 and revenue of $181.14M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.